2022
DOI: 10.1016/j.healun.2022.01.106
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Donation After Circulatory Death Heart Transplantation on Waitlist Outcomes and Transplantation Activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Even if heart procurement in cDCD has been reported for longer fWIT (>30 min) with early clinical outcomes similar to DBD or cDCD with short fWIT, 3,4 this is the first case in the world reporting such an extremely long controlled cardiac asystolia before using the heart for transplantation. Within the fWIT, the asystolic period is the time included between the circulatory death declaration (no-touch period onset) and the cardiac reperfusion initiation.…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…Even if heart procurement in cDCD has been reported for longer fWIT (>30 min) with early clinical outcomes similar to DBD or cDCD with short fWIT, 3,4 this is the first case in the world reporting such an extremely long controlled cardiac asystolia before using the heart for transplantation. Within the fWIT, the asystolic period is the time included between the circulatory death declaration (no-touch period onset) and the cardiac reperfusion initiation.…”
Section: Discussionmentioning
confidence: 92%
“…Cardiac magnetic resonance (CMR) on POD #20 documented ventricles with normal volumes, preserved regional and global systolic function, strain indexes, and wall thickness, no myopericardial late gadolinium enhancement (Figure 2). Endomyocardial biopsies performed on POD #18, POD #26, and POD #32 found grade 1R, grade 0, and grade 0 cellular rejection, respectively (according to current International Society of Heart and Lung Transplantation guidelines 3 ). Focal signs of myocardial ischemic damage were found (Figure 3).…”
Section: Resultsmentioning
confidence: 99%
“…Reducing indirect costs associated with these downstream events, such as the daily cost of CCRT (>$15K) may be another area of savings [41]. The cost reduction observed with taNRP has naturally translated into a greater documented contribution margin [42], and fueled explosive growth in implementation over the last few years. Based on UNOS data from 2019 to 2023, the use of NRP for DCD recoveries has increased over 250%, rising from 12.5% in 2019 to 44% in 2023 [43].…”
Section: Cost Analysismentioning
confidence: 99%